Global RNA Targeting Small Molecule Drug Discovery Market Report 2024

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024 – By Target RNA Type (Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)), By Technology (CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies), By Therapeutic Area (Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas), By Delivery Method (Intravenous (IV), Oral, Topical, Other Methods), By Application (Research Use, Therapeutic Use, Diagnostic Use, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

RNA Targeting Small Molecule Drug Discovery Market Definition And Segments

RNA targeting small-molecule drug discovery refers to identifying and developing small-molecule drugs that interact with RNA molecules to modulate their function or activity. This process is used for discovering innovative medicines that would be used for treating various diseases, including genetic disorders, viral infections, neurodegenerative diseases, and cancer.

The main target RNA types included in RNA targeting small molecule drug discovery are messenger RNA (mRNA), non-coding RNA (ncRNA), microRNA (miRNA), and long non-coding RNA (lncRNA). Messenger RNA (mRNA) is an RNA molecule that carries genetic information from the DNA in the cell's nucleus to the ribosomes, where protein synthesis occurs. The various technologies are CRISPR-cas9, RNA aptamers, small interfering RNA (siRNA), ribozymes, and others used in multiple therapeutic areas such as oncology, neurology, infectious disease, metabolic diseases, genetic disorders, and others. The various delivery methods are intravenous (IV), oral, topical, and others applied in research use, therapeutic use, diagnostic use, and others.

The RNA targeting small molecule drug discovery market covered in this report is segmented –

1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)

2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies

3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas

4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods

5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications

The RNA-targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $1.45 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to an increased understanding of disease genetics, genomic and proteomic discoveries, drug resistance challenges, investment in biotechnology and pharmaceutical research, rise of RNA therapeutics.

The RNA-targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to the expansion of RNA epigenetics research, RNA-seq and functional genomics, integration of artificial intelligence (AI), patient-centric approaches, and exosome-mediated drug delivery. Major trends in the forecast period include the emergence of RNA editing technologies, advancements in CRISPR technology, technological innovations, advancements in RNA biology, and RNA targeting in neurodegenerative diseases.

Rising Disease Burden Is A Catalyst For Growth In RNA-Targeted Small-Molecule Drug Discovery Market

The increasing prevalence of cancer, genetic disorders, and viral infections is expected to propel the growth of the RNA-targeted small-molecule drug discovery market going forward. Cancer is a group of diseases characterized by the uncontrollable growth of cells in the body. Viral infections refer to infections caused by viruses, tiny infectious agents that can only replicate inside the cells of living organisms. RNA targeting-based drug discovery is used to treat cancer, genetic disorders, and viral infections, as these diseases are linked with genes and malfunctioning genetic material, which can be treated using drugs developed using RNA targeting-based methods. For instance, in February 2021, according to the American Cancer Society, a US-based voluntary Health Organization, new cancer cases and cancer deaths number is expected to increase by 47% by 2040, reaching about 28.4 million cases. Furthermore, in 2021, according to the World Health Organization, a Switzerland-based specialized health agency of the United Nations, approximately 38.4 million people were living with HIV, and 650,000 people died due to HIV. Therefore, the increasing prevalence of cancer, genetic disorders, and viral infections drives the growth of the RNA-targeted small-molecule drug discovery market.

Rising Interest In Personalized Medicine Propels Advancements In RNA-Targeted Small-Molecule Drug Discovery Market

The growing interest in personalized medicine is expected to propel the growth of the RNA-targeting small-molecule drug discovery market going forward. Personalized medicine refers to an innovative approach to medical treatment and healthcare that tailors medical decisions, practices, interventions, and drug therapies to the individual patient. Personalized medicine in RNA-targeting small molecules can be designed with higher specificity, minimizing off-target effects and personalized to individual genetic variations. For instance, in October 2022, according to reports published by STAT, a US-based health-oriented news company, there were more than 75,000 genetic testing products and 300 personalized medicines. Therefore, the growing interest in personalized medicine is driving the growth of the RNA-targeting small-molecule drug discovery market.

Major companies operating in the RNA targeting small molecule drug discovery market report are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk Inc., ModeRNA Inc., Astellas Pharma Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., DiceRNA Pharmaceuticals Inc., Arrakis Therapeutics, Arbutus Biopharma Corporation, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics

Revolutionizing Small-Molecule Drug Discovery Through The Impact Of AI Integration In Pharmaceutical Research

Artificial intelligence (AI) integration in drug discovery is a key trend gaining popularity in the small-molecule drug discovery market. Major companies in the small molecule drug discovery market are leveraging AI technology to accelerate drug discovery procedures to sustain their position in the market. For instance, in May 2023, Google Cloud, the cloud computing suite of Google, a US-based technology company, launched the Target and Lead Identification Suite and Multiomics Suite to facilitate the drug discovery process. The Multiomics Suite expedites the identification and analysis of genetic data, assisting businesses in designing precision medicines. The Target and Lead Identification Suite aids researchers in better understanding the role of amino acids and predicting the structure of proteins.

Innovative Solutions In RNA-Targeting Small-Molecule Drug Discovery

Major companies operating in the RNA-targeting small-molecule drug discovery market are developing innovative platforms such as software-as-a-service platforms to gain a competitive edge in the market. Software-as-a-service (SaaS) is a software distribution model where applications are hosted by a third-party provider and made available to customers over the Internet. For instance, in December 2023, Merck & Co. Inc. a US-based science and technology company launched AIDDISON. The platform suggests the best ways to synthesize these selected medications. This innovative approach could result in huge cost savings for the drug discovery process and greatly increase the success rate of introducing novel medicines to patients. By bridging the gap between virtual molecular design and real-world manufacturability, the platform increases the success rate of delivering innovative treatments to patients by extracting hidden insights from large datasets. To accelerate the medication development process, this novel AI system integrates computer-aided drug design, machine learning, and generative AI.

Novo Nordisk Expands RNA-Based Drug Discovery Capabilities With Acquisition Of DiceRNA Pharmaceuticals

In December 2021, Novo Nordisk, a Denmark-based pharmaceutical company, acquired DiceRNA Pharmaceuticals for $3.3 billion. The acquisition added DiceRNA’s ribonucleic acid interference (RNAi) platform to Novo’s existing research tools and helped Novo develop novel therapeutics for the welfare of their patients. DiceRNA Pharmaceuticals is a US-based pharmaceutical company conducting work in RNA-based drug discovery.

North America was the largest region in the RNA-targeting small molecule drug discovery market in 2023. The regions covered in the RNA targeting small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the RNA targeting small molecule drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The RNA targeting small molecule drug discovery market consists of revenues earned by entities by providing hit identification, hit validation, and hit characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The RNA-targeting small molecule drug discovery market also includes sales of asRNAs and siRNAs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The RNA targeting small molecule drug discovery market research report is one of a series of new reports from The Business Research Company that provides RNA targeting small molecule drug discovery market statistics, including RNA targeting small molecule drug discovery industry global market size, regional shares, competitors with an RNA targeting small molecule drug discovery market share, detailed RNA targeting small molecule drug discovery market segments, market trends, and opportunities, and any further data you may need to thrive in the RNA targeting small molecule drug discovery industry. This RNA-targeting small molecule drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

RNA Targeting Small Molecule Drug Discovery Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.78 billion
Revenue Forecast In 2033 $3.97 billion
Growth Rate CAGR of 22.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled F. Hoffmann-La Roche Ltd ; Merck & Co. Inc; Bayer AG; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca PLC; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; Novo Nordisk Inc.; Moderna Inc.; Astellas Pharma Inc.; Biogen Inc.; Alnylam Pharmaceuticals Inc.; Sarepta Therapeutics Inc.; Evotec A.G.; PTC Therapeutics Inc.; Ionis Pharmaceuticals Inc.; Dicerna Pharmaceuticals Inc.; Arrakis Therapeutics; Arbutus Biopharma Corporation; H3 Biomedicine Inc.; Anima Biotech Inc.; Ribometrix Inc.; Quark Pharmaceuticals Inc.; Regulus Therapeutics Inc.; Skyhawk Therapeutics Inc.; Accent Therapeutics Inc.; Epics Therapeutics; Expansion Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. RNA Targeting Small Molecule Drug Discovery Market Characteristics

    3. RNA Targeting Small Molecule Drug Discovery Market Trends And Strategies

    4. RNA Targeting Small Molecule Drug Discovery Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global RNA Targeting Small Molecule Drug Discovery Market Size and Growth

    5.1. Global RNA Targeting Small Molecule Drug Discovery Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global RNA Targeting Small Molecule Drug Discovery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global RNA Targeting Small Molecule Drug Discovery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. RNA Targeting Small Molecule Drug Discovery Market Segmentation

    6.1. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Messenger RNA (mRNA)

    Non-Coding RNA (ncRNA)

    MicroRNA (miRNA)

    Long Non-Coding RNA (lnc RNA)

    6.2. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    CRISPR-Cas9

    RNA Aptamers

    Small Interfering RNA (siRNA)

    Ribozymes

    Other Technologies

    6.3. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Neurology

    Infectious Disease

    Metabolic Diseases

    Genetic Disorders

    Other Therapeutic Areas

    6.4. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Intravenous (IV)

    Oral

    Topical

    Other Methods

    6.5. Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Research Use

    Therapeutic Use

    Diagnostic Use

    Other Applications

    7. RNA Targeting Small Molecule Drug Discovery Market Regional And Country Analysis

    7.1. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market

    8.1. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China RNA Targeting Small Molecule Drug Discovery Market

    9.1. China RNA Targeting Small Molecule Drug Discovery Market Overview

    9.2. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India RNA Targeting Small Molecule Drug Discovery Market

    10.1. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan RNA Targeting Small Molecule Drug Discovery Market

    11.1. Japan RNA Targeting Small Molecule Drug Discovery Market Overview

    11.2. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia RNA Targeting Small Molecule Drug Discovery Market

    12.1. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia RNA Targeting Small Molecule Drug Discovery Market

    13.1. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea RNA Targeting Small Molecule Drug Discovery Market

    14.1. South Korea RNA Targeting Small Molecule Drug Discovery Market Overview

    14.2. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe RNA Targeting Small Molecule Drug Discovery Market

    15.1. Western Europe RNA Targeting Small Molecule Drug Discovery Market Overview

    15.2. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK RNA Targeting Small Molecule Drug Discovery Market

    16.1. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany RNA Targeting Small Molecule Drug Discovery Market

    17.1. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France RNA Targeting Small Molecule Drug Discovery Market

    18.5. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy RNA Targeting Small Molecule Drug Discovery Market

    19.9. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain RNA Targeting Small Molecule Drug Discovery Market

    20.13. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market

    21.1. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market Overview

    21.2. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia RNA Targeting Small Molecule Drug Discovery Market

    22.1. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America RNA Targeting Small Molecule Drug Discovery Market

    23.1. North America RNA Targeting Small Molecule Drug Discovery Market Overview

    23.2. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA RNA Targeting Small Molecule Drug Discovery Market

    24.1. USA RNA Targeting Small Molecule Drug Discovery Market Overview

    24.2. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada RNA Targeting Small Molecule Drug Discovery Market

    25.1. Canada RNA Targeting Small Molecule Drug Discovery Market Overview

    25.2. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America RNA Targeting Small Molecule Drug Discovery Market

    26.1. South America RNA Targeting Small Molecule Drug Discovery Market Overview

    26.2. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil RNA Targeting Small Molecule Drug Discovery Market

    27.1. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East RNA Targeting Small Molecule Drug Discovery Market

    28.1. Middle East RNA Targeting Small Molecule Drug Discovery Market Overview

    28.2. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa RNA Targeting Small Molecule Drug Discovery Market

    29.1. Africa RNA Targeting Small Molecule Drug Discovery Market Overview

    29.2. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape And Company Profiles

    30.1. RNA Targeting Small Molecule Drug Discovery Market Competitive Landscape

    30.2. RNA Targeting Small Molecule Drug Discovery Market Company Profiles

    30.2.1. F. Hoffmann-La Roche Ltd 

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Merck & Co. Inc

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bayer AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Novartis AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi SA

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. RNA Targeting Small Molecule Drug Discovery Market Other Major And Innovative Companies

    31.1. Bristol-Myers Squibb Company

    31.2. AstraZeneca PLC

    31.3. Takeda Pharmaceutical Company Limited

    31.4. Eli Lilly and Company

    31.5. Amgen Inc.

    31.6. Novo Nordisk Inc.

    31.7. Moderna Inc.

    31.8. Astellas Pharma Inc.

    31.9. Biogen Inc.

    31.10. Alnylam Pharmaceuticals Inc.

    31.11. Sarepta Therapeutics Inc.

    31.12. Evotec A.G.

    31.13. PTC Therapeutics Inc.

    31.14. Ionis Pharmaceuticals Inc.

    31.15. Dicerna Pharmaceuticals Inc.

    32. Global RNA Targeting Small Molecule Drug Discovery Market Competitive Benchmarking

    33. Global RNA Targeting Small Molecule Drug Discovery Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The RNA Targeting Small Molecule Drug Discovery Market

    35. RNA Targeting Small Molecule Drug Discovery Market Future Outlook and Potential Analysis

    35.1 RNA Targeting Small Molecule Drug Discovery Market In 2028 - Countries Offering Most New Opportunities

    35.2 RNA Targeting Small Molecule Drug Discovery Market In 2028 - Segments Offering Most New Opportunities

    35.3 RNA Targeting Small Molecule Drug Discovery Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: Asia-Pacific, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: China, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: India, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Japan, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Australia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: Indonesia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: South Korea, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: Western Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: UK, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: Germany, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: France, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Italy, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Spain, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Eastern Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: Russia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: North America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: USA, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: Canada, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: South America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Brazil, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Middle East, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Africa, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 76: F. Hoffmann-La Roche Ltd  Financial Performance
  • Table 77: Merck & Co. Inc Financial Performance
  • Table 78: Bayer AG Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Sanofi SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Delivery Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global RNA Targeting Small Molecule Drug Discovery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Global RNA Targeting Small Molecule Drug Discovery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: Asia-Pacific, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: China, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: India, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Japan, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Australia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: Indonesia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: South Korea, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: Western Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: UK, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: Germany, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: France, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Italy, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Spain, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Eastern Europe, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: Russia, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: North America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: USA, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: Canada, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: South America, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Brazil, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Middle East, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Target RNA Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Africa, RNA Targeting Small Molecule Drug Discovery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 76: F. Hoffmann-La Roche Ltd  Financial Performance
  • Figure 77: Merck & Co. Inc Financial Performance
  • Figure 78: Bayer AG Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Sanofi SA Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Drug Discovery Global Market Report 2024 – By Drug Type (Small Molecule, Large Molecule), By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation), By Technology (High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics and Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies), By Therapeutic Area (Oncology, Neurology, Infectious and Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas), By End User (Pharmaceutical Companies, CROs, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Drug Discovery Services Global Market Report 2024 – By Type( Chemistry Services, Biology Services), By Process( Target Selection, Target Validation, Hit-to-Lead identification, Lead Optimization, Candidate Validation), By Drug Type( Biologics Drug , Small Molecule Drug), By End user( Pharmaceutical and Biotechnology Companies, Academic Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Drug Discovery Informatics Global Market Report 2024 – By Service (In-House, Outsourced), By Modality (Cloud-Based Systems, In-Campus), By Application (Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis), By End-User (Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Small Molecule Drug Discovery Global Market Report 2024 – By Drug Type (Small Molecule Drugs, Biologic Drugs), By Technology (High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others), By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others), By Process/Phase (Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization), By End-User (Pharmaceutical Companies, Contract Research Organizations, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2024 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecules, Large Molecules), By Therapeutic Type (Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Virtual Clinical Trials Global Market Report 2024 – By Design (Observational Trials, Interventional Trials, Expanded Access Trials), By Phases (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Other Indications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Pediatric Clinical Trials Global Market Report 2024 – By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Treatment Studies, Observational Studies), By Therapeutic Areas (Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas) – Market Size, Trends, And Global Forecast 2024-2033
View Report
AI In Clinical Trials Global Market Report 2024 – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Technology (Machine Learning, Deep Learning, Supervised Learning, Other Technologies), By Application (Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology diseases, Other Applications), By End-User (Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the RNA targeting small molecule drug discovery market?

RNA targeting small-molecule drug discovery refers to identifying and developing small-molecule drugs that interact with RNA molecules to modulate their function or activity. This process is used for discovering innovative medicines that would be used for treating various diseases, including genetic disorders, viral infections, neurodegenerative diseases, and cancer. For further insights on the RNA targeting small molecule drug discovery market, request a sample here

How will the RNA targeting small molecule drug discovery market drivers and restraints affect the RNA targeting small molecule drug discovery market dynamics? What forces will shape the RNA targeting small molecule drug discovery industry going forward?

The RNA targeting small molecule drug discovery market major growth driver - Rising Disease Burden Is A Catalyst For Growth In Rna-Targeted Small-Molecule Drug Discovery Market. For further insights on the RNA targeting small molecule drug discovery marke request a sample here

What is the forecast market size or the forecast market value of the RNA targeting small molecule drug discovery market?

The RNA targeting small molecule drug discovery market size has grown exponentially in recent years. It will grow from $1.45 billion in 2023 to $1.78 billion in 2024 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to increased understanding of disease genetics, genomic and proteomic discoveries, drug resistance challenges, investment in biotechnology and pharmaceutical research, rise of rna therapeutics. The RNA targeting small molecule drug discovery market size is expected to see exponential growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to expansion of rna epigenetics research, rna-seq and functional genomics, integration of artificial intelligence (ai),patient-centric approaches, exosome-mediated drug delivery. Major trends in the forecast period include emergence of rna editing technologies, advancements in crispr technology, technological innovations, advancements in rna biology, rna targeting in neurodegenerative diseases. For further insights on the RNA targeting small molecule drug discovery market, request a sample here

How is the RNA targeting small molecule drug discovery market segmented?

The RNA targeting small molecule drug discovery market is segmented
1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other ApplicationsFor further insights on the RNA targeting small molecule drug discovery market, request a sample here

Which region has the largest share of the RNA targeting small molecule drug discovery market? What are the other regions covered in the report?

North America was the largest region in the RNA targeting small molecule drug discovery market in 2023. The regions covered in the RNA targeting small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the RNA targeting small molecule drug discovery market, request a sample here.

Who are the major players in the RNA targeting small molecule drug discovery market?

Major companies operating in the RNA targeting small molecule drug discovery market report are F. Hoffmann-La Roche Ltd , Merck & Co. Inc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk Inc., Moderna Inc., Astellas Pharma Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, Arbutus Biopharma Corporation, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics For further insights on the RNA targeting small molecule drug discovery market, request a sample here.

What are the key trends in the RNA targeting small molecule drug discovery market?

Major trend in the RNA targeting small molecule drug discovery market - Revolutionizing Small-Molecule Drug Discovery Through The Impact Of AI Integration In Pharmaceutical Research. For further insights on the RNA targeting small molecule drug discovery request a sample here.

What are the major opportunities in the RNA targeting small molecule drug discovery market? What are the strategies for the RNA targeting small molecule drug discovery market?

For detailed insights on the major opportunities and strategies in the RNA targeting small molecule drug discovery market, request a sample here.

How does the RNA targeting small molecule drug discovery market relate to the overall economy and other similar markets?

For detailed insights on RNA targeting small molecule drug discovery market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the RNA targeting small molecule drug discovery industry?

For detailed insights on the mergers and acquisitions in the RNA targeting small molecule drug discovery industry, request a sample here.

What are the key dynamics influencing the RNA targeting small molecule drug discovery market growth? SWOT analysis of the RNA targeting small molecule drug discovery market.

For detailed insights on the key dynamics influencing the RNA targeting small molecule drug discovery market growth and SWOT analysis of the RNA targeting small molecule drug discovery industry, request a sample here.